Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ARV1 | Human | developmental and epileptic encephalopathy 38 | | IAGP | | 7240710 | | OMIM | | |
|
Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ARV1 | Human | developmental and epileptic encephalopathy 38 | | IAGP | | 7240710 | | OMIM | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
3. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:11063737 | PMID:12145310 | PMID:12477932 | PMID:14702039 | PMID:15489334 | PMID:16196087 | PMID:16710414 | PMID:17207965 | PMID:20663892 | PMID:21873635 | PMID:21890473 | PMID:21963094 |
PMID:24273168 | PMID:26186194 | PMID:26460143 | PMID:26496610 | PMID:27104745 | PMID:27270415 | PMID:28298427 | PMID:28514442 | PMID:29987050 | PMID:32165008 | PMID:32296183 | PMID:32462292 |
PMID:33961781 | PMID:34186245 | PMID:34296759 | PMID:35271311 | PMID:35696571 | PMID:37314216 |
ARV1 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arv1 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arv1 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arv1 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARV1 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARV1 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arv1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARV1 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARV1 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arv1 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in ARV1
43 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
NM_022786.3(ARV1):c.175-10A>C | single nucleotide variant | not provided [RCV000914397] | Chr1:230988310 [GRCh38] Chr1:231124056 [GRCh37] Chr1:1q42.2 |
likely benign |
GRCh38/hg38 1q42.2(chr1:230519755-231232066)x3 | copy number gain | See cases [RCV000050291] | Chr1:230519755..231232066 [GRCh38] Chr1:230655501..231367812 [GRCh37] Chr1:228722124..229434435 [NCBI36] Chr1:1q42.2 |
uncertain significance |
GRCh38/hg38 1q32.3-44(chr1:214023812-248918469)x3 | copy number gain | See cases [RCV000050981] | Chr1:214023812..248918469 [GRCh38] Chr1:214197155..249212668 [GRCh37] Chr1:212263778..247179291 [NCBI36] Chr1:1q32.3-44 |
pathogenic |
GRCh38/hg38 1q41-44(chr1:223347693-248918469)x3 | copy number gain | See cases [RCV000050581] | Chr1:223347693..248918469 [GRCh38] Chr1:223521035..249212668 [GRCh37] Chr1:221587658..247179291 [NCBI36] Chr1:1q41-44 |
pathogenic |
GRCh38/hg38 1q42.13-42.2(chr1:229883805-231517553)x3 | copy number gain | See cases [RCV000051559] | Chr1:229883805..231517553 [GRCh38] Chr1:230019552..231653299 [GRCh37] Chr1:228086175..229719922 [NCBI36] Chr1:1q42.13-42.2 |
uncertain significance |
GRCh38/hg38 1q42.13-42.2(chr1:230489657-231243203)x3 | copy number gain | See cases [RCV000051560] | Chr1:230489657..231243203 [GRCh38] Chr1:230625403..231378949 [GRCh37] Chr1:228692026..229445572 [NCBI36] Chr1:1q42.13-42.2 |
uncertain significance |
GRCh38/hg38 1q42.13-44(chr1:230106271-243677283)x1 | copy number loss | See cases [RCV000051082] | Chr1:230106271..243677283 [GRCh38] Chr1:230242018..243840585 [GRCh37] Chr1:228308641..241907208 [NCBI36] Chr1:1q42.13-44 |
pathogenic |
GRCh38/hg38 1q41-44(chr1:221902539-248918469)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051875]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051875]|See cases [RCV000051875] | Chr1:221902539..248918469 [GRCh38] Chr1:222075881..249212668 [GRCh37] Chr1:220142504..247179291 [NCBI36] Chr1:1q41-44 |
pathogenic |
GRCh38/hg38 1q41-44(chr1:223828500-248891309)x3 | copy number gain | See cases [RCV000051878] | Chr1:223828500..248891309 [GRCh38] Chr1:224016202..249185508 [GRCh37] Chr1:222082825..247152131 [NCBI36] Chr1:1q41-44 |
pathogenic |
GRCh38/hg38 1q41-44(chr1:223887780-248891309)x3 | copy number gain | See cases [RCV000051880] | Chr1:223887780..248891309 [GRCh38] Chr1:224075482..249185508 [GRCh37] Chr1:222142105..247152131 [NCBI36] Chr1:1q41-44 |
pathogenic |
GRCh38/hg38 1q32.2-44(chr1:209646207-248931113)x3 | copy number gain | See cases [RCV000051861] | Chr1:209646207..248931113 [GRCh38] Chr1:209819552..249225312 [GRCh37] Chr1:207886175..247191935 [NCBI36] Chr1:1q32.2-44 |
pathogenic |
GRCh38/hg38 1q42.11-44(chr1:224096488-248918469)x3 | copy number gain | See cases [RCV000051882] | Chr1:224096488..248918469 [GRCh38] Chr1:224284190..249212668 [GRCh37] Chr1:222350813..247179291 [NCBI36] Chr1:1q42.11-44 |
pathogenic |
GRCh38/hg38 1q42.2(chr1:230749331-231192557)x1 | copy number loss | See cases [RCV000133617] | Chr1:230749331..231192557 [GRCh38] Chr1:230885077..231328303 [GRCh37] Chr1:228951700..229394926 [NCBI36] Chr1:1q42.2 |
uncertain significance |
GRCh38/hg38 1q32.2-44(chr1:209963625-248918469)x3 | copy number gain | See cases [RCV000134979] | Chr1:209963625..248918469 [GRCh38] Chr1:210136970..249212668 [GRCh37] Chr1:208203593..247179291 [NCBI36] Chr1:1q32.2-44 |
pathogenic |
GRCh38/hg38 1q41-44(chr1:223815147-248918469)x3 | copy number gain | See cases [RCV000135839] | Chr1:223815147..248918469 [GRCh38] Chr1:224002849..249212668 [GRCh37] Chr1:222069472..247179291 [NCBI36] Chr1:1q41-44 |
pathogenic |
GRCh38/hg38 1q42.12-42.2(chr1:226185124-232872488)x1 | copy number loss | See cases [RCV000135796] | Chr1:226185124..232872488 [GRCh38] Chr1:226372825..233008234 [GRCh37] Chr1:224439448..231074857 [NCBI36] Chr1:1q42.12-42.2 |
pathogenic |
GRCh38/hg38 1q42.13-44(chr1:229022909-248918469)x3 | copy number gain | See cases [RCV000136666] | Chr1:229022909..248918469 [GRCh38] Chr1:229158656..249212668 [GRCh37] Chr1:227225279..247179291 [NCBI36] Chr1:1q42.13-44 |
pathogenic |
GRCh38/hg38 1q42.11-44(chr1:224022862-248918469)x3 | copy number gain | See cases [RCV000137769] | Chr1:224022862..248918469 [GRCh38] Chr1:224210564..249212668 [GRCh37] Chr1:222277187..247179291 [NCBI36] Chr1:1q42.11-44 |
pathogenic |
GRCh38/hg38 1q42.12-44(chr1:225438480-248787200)x3 | copy number gain | See cases [RCV000142448] | Chr1:225438480..248787200 [GRCh38] Chr1:225626182..249060210 [GRCh37] Chr1:223692805..247048022 [NCBI36] Chr1:1q42.12-44 |
pathogenic |
NM_022786.3(ARV1):c.94T>C (p.Tyr32His) | single nucleotide variant | not provided [RCV000515018] | Chr1:230979199 [GRCh38] Chr1:231114945 [GRCh37] Chr1:1q42.2 |
benign|likely benign |
GRCh38/hg38 1q32.2-44(chr1:207346642-248930485)x3 | copy number gain | See cases [RCV000143727] | Chr1:207346642..248930485 [GRCh38] Chr1:207519987..249224684 [GRCh37] Chr1:205586610..247191307 [NCBI36] Chr1:1q32.2-44 |
pathogenic |
GRCh38/hg38 1q42.2(chr1:230519755-231232066)x3 | copy number gain | See cases [RCV000148222] | Chr1:230519755..231232066 [GRCh38] Chr1:230655501..231367812 [GRCh37] Chr1:228722124..229434435 [NCBI36] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.565G>A (p.Gly189Arg) | single nucleotide variant | Abnormality of the nervous system [RCV001814076]|Blindness [RCV000162175]|Developmental and epileptic encephalopathy, 38 [RCV000235018] | Chr1:230995876 [GRCh38] Chr1:231131622 [GRCh37] Chr1:1q42.2 |
pathogenic|likely pathogenic |
NM_022786.3(ARV1):c.294+1G>A | single nucleotide variant | ARV1-related disorder [RCV000234848]|Developmental and epileptic encephalopathy, 38 [RCV000235015] | Chr1:230988440 [GRCh38] Chr1:231124186 [GRCh37] Chr1:1q42.2 |
pathogenic |
GRCh37/hg19 1q31.3-44(chr1:195483439-249213000)x3 | copy number gain | See cases [RCV000449172] | Chr1:195483439..249213000 [GRCh37] Chr1:1q31.3-44 |
pathogenic |
GRCh37/hg19 1q41-44(chr1:214697099-249224684)x3 | copy number gain | See cases [RCV000449210] | Chr1:214697099..249224684 [GRCh37] Chr1:1q41-44 |
pathogenic |
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)x3 | copy number gain | See cases [RCV000510383] | Chr1:849467..249224684 [GRCh37] Chr1:1p36.33-q44 |
pathogenic |
NM_022786.3(ARV1):c.656A>C (p.Asn219Thr) | single nucleotide variant | Inborn genetic diseases [RCV002524037]|See cases [RCV002252139]|not provided [RCV000493727] | Chr1:230995967 [GRCh38] Chr1:231131713 [GRCh37] Chr1:1q42.2 |
uncertain significance |
GRCh37/hg19 1q42.13-42.2(chr1:230619349-231413907)x3 | copy number gain | See cases [RCV000511859] | Chr1:230619349..231413907 [GRCh37] Chr1:1q42.13-42.2 |
uncertain significance |
GRCh37/hg19 1q42.11-44(chr1:224105294-249224684)x3 | copy number gain | See cases [RCV000510981] | Chr1:224105294..249224684 [GRCh37] Chr1:1q42.11-44 |
pathogenic |
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684) | copy number gain | See cases [RCV000510926] | Chr1:849467..249224684 [GRCh37] Chr1:1p36.33-q44 |
pathogenic |
NM_022786.3(ARV1):c.217C>T (p.Pro73Ser) | single nucleotide variant | Inborn genetic diseases [RCV003261502] | Chr1:230988362 [GRCh38] Chr1:231124108 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.674-2A>T | single nucleotide variant | Developmental and epileptic encephalopathy, 38 [RCV000626020]|Inborn genetic diseases [RCV000623178] | Chr1:230997119 [GRCh38] Chr1:231132865 [GRCh37] Chr1:1q42.2 |
pathogenic|uncertain significance |
t(1;3)(q44;p25)dn | translocation | not specified [RCV000714249] | Chr1:231122975..231122976 [GRCh37] Chr3:28822575..28822579 [GRCh37] Chr1:1q42.2 Chr3:3p24.1 |
uncertain significance |
GRCh37/hg19 1q41-44(chr1:218252551-249224684)x3 | copy number gain | not provided [RCV000684700] | Chr1:218252551..249224684 [GRCh37] Chr1:1q41-44 |
pathogenic |
GRCh37/hg19 1q42.13-44(chr1:228529973-249181598)x3 | copy number gain | not provided [RCV000684707] | Chr1:228529973..249181598 [GRCh37] Chr1:1q42.13-44 |
pathogenic |
GRCh37/hg19 1p36.33-q44(chr1:47851-249228449)x3 | copy number gain | not provided [RCV000736295] | Chr1:47851..249228449 [GRCh37] Chr1:1p36.33-q44 |
pathogenic |
GRCh37/hg19 1p36.33-q44(chr1:82154-249218992)x3 | copy number gain | not provided [RCV000736305] | Chr1:82154..249218992 [GRCh37] Chr1:1p36.33-q44 |
pathogenic |
NM_022786.3(ARV1):c.732G>A (p.Leu244=) | single nucleotide variant | not provided [RCV001532577] | Chr1:230997179 [GRCh38] Chr1:231132925 [GRCh37] Chr1:1q42.2 |
likely benign |
NM_022786.3(ARV1):c.64A>T (p.Thr22Ser) | single nucleotide variant | ARV1-related disorder [RCV003905787]|not provided [RCV000958554]|not specified [RCV001819017] | Chr1:230979169 [GRCh38] Chr1:231114915 [GRCh37] Chr1:1q42.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_022786.3(ARV1):c.528C>T (p.Phe176=) | single nucleotide variant | ARV1-related disorder [RCV003933084]|not provided [RCV000918785] | Chr1:230995839 [GRCh38] Chr1:231131585 [GRCh37] Chr1:1q42.2 |
benign|likely benign |
NM_022786.3(ARV1):c.360A>G (p.Gln120=) | single nucleotide variant | not provided [RCV000899123] | Chr1:230990175 [GRCh38] Chr1:231125921 [GRCh37] Chr1:1q42.2 |
likely benign |
NM_022786.3(ARV1):c.302G>A (p.Gly101Glu) | single nucleotide variant | ARV1-related disorder [RCV003962887]|not provided [RCV000972068] | Chr1:230990117 [GRCh38] Chr1:231125863 [GRCh37] Chr1:1q42.2 |
benign |
GRCh37/hg19 1q25.3-44(chr1:182388773-249111240)x3 | copy number gain | not provided [RCV000845852] | Chr1:182388773..249111240 [GRCh37] Chr1:1q25.3-44 |
pathogenic |
GRCh37/hg19 1q41-43(chr1:219916966-239004378)x3 | copy number gain | not provided [RCV001005175] | Chr1:219916966..239004378 [GRCh37] Chr1:1q41-43 |
pathogenic |
GRCh37/hg19 1q32.2-44(chr1:210152794-249218992)x3 | copy number gain | See cases [RCV001194578] | Chr1:210152794..249218992 [GRCh37] Chr1:1q32.2-44 |
pathogenic |
NM_022786.3(ARV1):c.517_518insC (p.Lys173fs) | insertion | not provided [RCV001008423] | Chr1:230995828..230995829 [GRCh38] Chr1:231131574..231131575 [GRCh37] Chr1:1q42.2 |
likely pathogenic |
GRCh37/hg19 1q42.2(chr1:230921930-231387086)x3 | copy number gain | not provided [RCV000847404] | Chr1:230921930..231387086 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.73G>T (p.Ala25Ser) | single nucleotide variant | ARV1-related disorder [RCV003958303]|Inborn genetic diseases [RCV004669168]|not provided [RCV000909691] | Chr1:230979178 [GRCh38] Chr1:231114924 [GRCh37] Chr1:1q42.2 |
likely benign |
GRCh37/hg19 1q42.13-42.2(chr1:230616084-231410027)x3 | copy number gain | not provided [RCV001005189] | Chr1:230616084..231410027 [GRCh37] Chr1:1q42.13-42.2 |
uncertain significance |
GRCh37/hg19 1q42.13-43(chr1:228832737-240993877)x3 | copy number gain | not provided [RCV001005187] | Chr1:228832737..240993877 [GRCh37] Chr1:1q42.13-43 |
pathogenic |
GRCh37/hg19 1q32.1-44(chr1:204045948-249218992)x3 | copy number gain | See cases [RCV001007407] | Chr1:204045948..249218992 [GRCh37] Chr1:1q32.1-44 |
pathogenic |
NM_022786.3(ARV1):c.101G>A (p.Cys34Tyr) | single nucleotide variant | Developmental and epileptic encephalopathy, 38 [RCV001655670]|not provided [RCV001046333] | Chr1:230979206 [GRCh38] Chr1:231114952 [GRCh37] Chr1:1q42.2 |
uncertain significance |
GRCh37/hg19 1q41-42.2(chr1:223653722-234591807)x1 | copy number loss | not provided [RCV001005180] | Chr1:223653722..234591807 [GRCh37] Chr1:1q41-42.2 |
pathogenic |
NM_022786.3(ARV1):c.518dup (p.Pro174fs) | duplication | Developmental and epileptic encephalopathy, 38 [RCV001655669]|not provided [RCV001040844] | Chr1:230995820..230995821 [GRCh38] Chr1:231131566..231131567 [GRCh37] Chr1:1q42.2 |
pathogenic|likely pathogenic |
NC_000001.10:g.(?_130980840)_(248900000_?)dup | duplication | Gastrointestinal stromal tumor [RCV001300221]|Parathyroid carcinoma [RCV001341077] | Chr1:130980840..248900000 [GRCh37] Chr1:1q12-44 |
uncertain significance |
NM_022786.3(ARV1):c.175-11T>C | single nucleotide variant | Developmental and epileptic encephalopathy, 38 [RCV001554173]|not provided [RCV004715519] | Chr1:230988309 [GRCh38] Chr1:231124055 [GRCh37] Chr1:1q42.2 |
benign |
NM_022786.3(ARV1):c.363_364del (p.Ser122fs) | deletion | Developmental and epileptic encephalopathy, 38 [RCV001262173] | Chr1:230990178..230990179 [GRCh38] Chr1:231125924..231125925 [GRCh37] Chr1:1q42.2 |
likely pathogenic |
NM_022786.3(ARV1):c.292_294+1del | deletion | Developmental and epileptic encephalopathy, 38 [RCV001262616] | Chr1:230988437..230988440 [GRCh38] Chr1:231124183..231124186 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.175-2A>G | single nucleotide variant | Developmental and epileptic encephalopathy, 38 [RCV001329920] | Chr1:230988318 [GRCh38] Chr1:231124064 [GRCh37] Chr1:1q42.2 |
likely pathogenic |
NM_022786.3(ARV1):c.*4+1G>A | single nucleotide variant | ARV1-related disorder [RCV003954091]|not provided [RCV003329854]|not specified [RCV004765801] | Chr1:230997268 [GRCh38] Chr1:231133014 [GRCh37] Chr1:1q42.2 |
pathogenic|likely benign|uncertain significance |
NM_022786.3(ARV1):c.29A>G (p.Gln10Arg) | single nucleotide variant | Developmental and epileptic encephalopathy, 38 [RCV001336587] | Chr1:230979134 [GRCh38] Chr1:231114880 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.309_310del (p.Cys104fs) | microsatellite | not provided [RCV001291569] | Chr1:230990122..230990123 [GRCh38] Chr1:231125868..231125869 [GRCh37] Chr1:1q42.2 |
likely pathogenic |
NM_022786.3(ARV1):c.448+1G>T | single nucleotide variant | not provided [RCV001377260] | Chr1:230990264 [GRCh38] Chr1:231126010 [GRCh37] Chr1:1q42.2 |
likely pathogenic |
NM_022786.3(ARV1):c.518del (p.Lys173fs) | deletion | not provided [RCV003159363] | Chr1:230995821 [GRCh38] Chr1:231131567 [GRCh37] Chr1:1q42.2 |
likely pathogenic |
GRCh37/hg19 1q42.12-42.2(chr1:226131690-231908227) | copy number loss | not specified [RCV002052878] | Chr1:226131690..231908227 [GRCh37] Chr1:1q42.12-42.2 |
likely pathogenic |
GRCh37/hg19 1q42.13-42.2(chr1:228214912-231483538) | copy number loss | not specified [RCV002052889] | Chr1:228214912..231483538 [GRCh37] Chr1:1q42.13-42.2 |
pathogenic |
NM_022786.3(ARV1):c.175-3_175-2inv | inversion | Developmental and epileptic encephalopathy, 38 [RCV001843749] | Chr1:230988317..230988318 [GRCh38] Chr1:231124063..231124064 [GRCh37] Chr1:1q42.2 |
pathogenic |
NM_022786.3(ARV1):c.2T>C (p.Met1Thr) | single nucleotide variant | not provided [RCV001824506] | Chr1:230979107 [GRCh38] Chr1:231114853 [GRCh37] Chr1:1q42.2 |
likely pathogenic |
NC_000001.10:g.(?_229567246)_(232172577_?)dup | duplication | Actin accumulation myopathy [RCV003120751]|not provided [RCV001943051] | Chr1:229567246..232172577 [GRCh37] Chr1:1q42.13-42.2 |
uncertain significance|no classifications from unflagged records |
NC_000001.10:g.(?_230203028)_(231413288_?)del | deletion | Congenital disorder of glycosylation, type IIq [RCV003109448]|not provided [RCV003113491] | Chr1:230203028..231413288 [GRCh37] Chr1:1q42.13-42.2 |
pathogenic|no classifications from unflagged records |
NC_000001.10:g.(?_229567246)_(231413288_?)del | deletion | not provided [RCV003116710] | Chr1:229567246..231413288 [GRCh37] Chr1:1q42.13-42.2 |
pathogenic |
NM_022786.3(ARV1):c.746T>A (p.Val249Asp) | single nucleotide variant | not provided [RCV002288115] | Chr1:230997193 [GRCh38] Chr1:231132939 [GRCh37] Chr1:1q42.2 |
uncertain significance |
GRCh37/hg19 1q31.3-44(chr1:197867914-249224684)x3 | copy number gain | See cases [RCV002287837] | Chr1:197867914..249224684 [GRCh37] Chr1:1q31.3-44 |
pathogenic |
GRCh37/hg19 1q42.13-43(chr1:227992928-236659905)x3 | copy number gain | not provided [RCV002475638] | Chr1:227992928..236659905 [GRCh37] Chr1:1q42.13-43 |
likely pathogenic |
NM_022786.3(ARV1):c.573_574del (p.Leu192fs) | microsatellite | Developmental and epileptic encephalopathy, 38 [RCV002510669] | Chr1:230995882..230995883 [GRCh38] Chr1:231131628..231131629 [GRCh37] Chr1:1q42.2 |
likely pathogenic |
GRCh37/hg19 1q41-44(chr1:223972939-249224684)x3 | copy number gain | not provided [RCV002475745] | Chr1:223972939..249224684 [GRCh37] Chr1:1q41-44 |
pathogenic |
GRCh37/hg19 1q42.2(chr1:231126647-231194176)x1 | copy number loss | not provided [RCV002475818] | Chr1:231126647..231194176 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.646C>T (p.Leu216Phe) | single nucleotide variant | Inborn genetic diseases [RCV002911632] | Chr1:230995957 [GRCh38] Chr1:231131703 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.502A>G (p.Met168Val) | single nucleotide variant | Inborn genetic diseases [RCV002781834] | Chr1:230995813 [GRCh38] Chr1:231131559 [GRCh37] Chr1:1q42.2 |
uncertain significance |
GRCh37/hg19 1q42.11-43(chr1:224230307-243181599)x3 | copy number gain | not provided [RCV002509019] | Chr1:224230307..243181599 [GRCh37] Chr1:1q42.11-43 |
not provided |
NM_022786.3(ARV1):c.667A>G (p.Ile223Val) | single nucleotide variant | Inborn genetic diseases [RCV002944373] | Chr1:230995978 [GRCh38] Chr1:231131724 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.475T>A (p.Phe159Ile) | single nucleotide variant | Inborn genetic diseases [RCV003218640] | Chr1:230995786 [GRCh38] Chr1:231131532 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.691C>T (p.Arg231Cys) | single nucleotide variant | Developmental and epileptic encephalopathy, 38 [RCV003141548] | Chr1:230997138 [GRCh38] Chr1:231132884 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.148del (p.His50fs) | deletion | Inborn genetic diseases [RCV003198049] | Chr1:230979252 [GRCh38] Chr1:231114998 [GRCh37] Chr1:1q42.2 |
pathogenic |
GRCh38/hg38 1q42.13-44(chr1:230178121-243646135)x1 | copy number loss | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 [RCV003327728] | Chr1:230178121..243646135 [GRCh38] Chr1:1q42.13-44 |
pathogenic |
NM_022786.3(ARV1):c.594_595del (p.Ile198fs) | deletion | Developmental and epileptic encephalopathy, 38 [RCV003444167] | Chr1:230995904..230995905 [GRCh38] Chr1:231131650..231131651 [GRCh37] Chr1:1q42.2 |
likely pathogenic |
NM_022786.3(ARV1):c.712G>A (p.Val238Met) | single nucleotide variant | Inborn genetic diseases [RCV003372077] | Chr1:230997159 [GRCh38] Chr1:231132905 [GRCh37] Chr1:1q42.2 |
likely benign |
GRCh37/hg19 1q42.13-43(chr1:230231959-238032346)x1 | copy number loss | not provided [RCV003484077] | Chr1:230231959..238032346 [GRCh37] Chr1:1q42.13-43 |
pathogenic |
GRCh37/hg19 1q42.13-44(chr1:229373250-249206595)x3 | copy number gain | not provided [RCV003484052] | Chr1:229373250..249206595 [GRCh37] Chr1:1q42.13-44 |
pathogenic |
NM_022786.3(ARV1):c.81G>T (p.Ser27=) | single nucleotide variant | not provided [RCV003414945] | Chr1:230979186 [GRCh38] Chr1:231114932 [GRCh37] Chr1:1q42.2 |
likely benign |
NM_022786.3(ARV1):c.214G>A (p.Asp72Asn) | single nucleotide variant | not provided [RCV003414946] | Chr1:230988359 [GRCh38] Chr1:231124105 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.295-5A>G | single nucleotide variant | not provided [RCV003414947] | Chr1:230990105 [GRCh38] Chr1:231125851 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.125A>G (p.Lys42Arg) | single nucleotide variant | Inborn genetic diseases [RCV004418320] | Chr1:230979230 [GRCh38] Chr1:231114976 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.761G>A (p.Ser254Asn) | single nucleotide variant | Inborn genetic diseases [RCV004418327] | Chr1:230997208 [GRCh38] Chr1:231132954 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.655A>C (p.Asn219His) | single nucleotide variant | not provided [RCV003887315] | Chr1:230995966 [GRCh38] Chr1:231131712 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.692G>A (p.Arg231His) | single nucleotide variant | Inborn genetic diseases [RCV004418325] | Chr1:230997139 [GRCh38] Chr1:231132885 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.759G>C (p.Gln253His) | single nucleotide variant | Inborn genetic diseases [RCV004418326] | Chr1:230997206 [GRCh38] Chr1:231132952 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.655A>G (p.Asn219Asp) | single nucleotide variant | Inborn genetic diseases [RCV004418324] | Chr1:230995966 [GRCh38] Chr1:231131712 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.354G>C (p.Gln118His) | single nucleotide variant | Inborn genetic diseases [RCV004418322] | Chr1:230990169 [GRCh38] Chr1:231125915 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.545C>T (p.Ala182Val) | single nucleotide variant | Inborn genetic diseases [RCV004418323] | Chr1:230995856 [GRCh38] Chr1:231131602 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.9C>T (p.Asn3=) | single nucleotide variant | ARV1-related disorder [RCV003962198] | Chr1:230979114 [GRCh38] Chr1:231114860 [GRCh37] Chr1:1q42.2 |
likely benign |
NM_022786.3(ARV1):c.283A>C (p.Thr95Pro) | single nucleotide variant | ARV1-related disorder [RCV004733863] | Chr1:230988428 [GRCh38] Chr1:231124174 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.179C>A (p.Ser60Tyr) | single nucleotide variant | Inborn genetic diseases [RCV004418321] | Chr1:230988324 [GRCh38] Chr1:231124070 [GRCh37] Chr1:1q42.2 |
uncertain significance |
NM_022786.3(ARV1):c.49G>A (p.Asp17Asn) | single nucleotide variant | Inborn genetic diseases [RCV003357795] | Chr1:230979154 [GRCh38] Chr1:231114900 [GRCh37] Chr1:1q42.2 |
uncertain significance |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
The following QTLs overlap with this region. | Full Report | CSV | TAB | Printer | Gviewer |
A007E06 |
|
adipose tissue
|
alimentary part of gastrointestinal system
|
appendage
|
circulatory system
|
ectoderm
|
endocrine system
|
endoderm
|
entire extraembryonic component
|
exocrine system
|
hemolymphoid system
|
hepatobiliary system
|
integumental system
|
mesenchyme
|
mesoderm
|
musculoskeletal system
|
nervous system
|
pharyngeal arch
|
renal system
|
reproductive system
|
respiratory system
|
sensory system
|
visual system
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1204 | 2439 | 2788 | 2253 | 4974 | 1726 | 2351 | 6 | 624 | 1951 | 465 | 2270 | 7306 | 6472 | 53 | 3734 | 1 | 852 | 1744 | 1617 | 174 | 1 |
Ensembl Acc Id: | ENST00000310256 ⟹ ENSP00000312458 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000366658 ⟹ ENSP00000355618 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000435927 ⟹ ENSP00000394547 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000450711 ⟹ ENSP00000416039 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000459891 ⟹ ENSP00000435420 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000480519 ⟹ ENSP00000436763 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000497753 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001346992 ⟹ NP_001333921 | ||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
||||||||||||
Sequence: |
RefSeq Acc Id: | NM_022786 ⟹ NP_073623 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NR_144538 | ||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||
Type: | NON-CODING | ||||||||||||
Position: |
|
||||||||||||
Sequence: |
RefSeq Acc Id: | XM_024449202 ⟹ XP_024304970 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_054338307 ⟹ XP_054194282 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XR_002957381 | ||||||||
Type: | NON-CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XR_007063028 | ||||||||
Type: | NON-CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XR_008486142 | ||||||||
Type: | NON-CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XR_008486143 | ||||||||
Type: | NON-CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NP_073623 ⟸ NM_022786 |
- Peptide Label: | isoform 2 |
- UniProtKB: | Q9H5V6 (UniProtKB/Swiss-Prot), Q9H2H2 (UniProtKB/Swiss-Prot), Q5VSP2 (UniProtKB/Swiss-Prot), Q5VSP0 (UniProtKB/Swiss-Prot), Q5VSN9 (UniProtKB/Swiss-Prot), Q5VSN8 (UniProtKB/Swiss-Prot), Q5VSN7 (UniProtKB/Swiss-Prot), A8KAI4 (UniProtKB/Swiss-Prot), Q9UFF5 (UniProtKB/Swiss-Prot), Q9H2C2 (UniProtKB/Swiss-Prot), H7C484 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001333921 ⟸ NM_001346992 |
- Peptide Label: | isoform 1 |
- UniProtKB: | H7C0E7 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | XP_024304970 ⟸ XM_024449202 |
- Peptide Label: | isoform X1 |
- UniProtKB: | H7C0E7 (UniProtKB/TrEMBL) |
- Sequence: |
Ensembl Acc Id: | ENSP00000416039 ⟸ ENST00000450711 |
Ensembl Acc Id: | ENSP00000436763 ⟸ ENST00000480519 |
Ensembl Acc Id: | ENSP00000312458 ⟸ ENST00000310256 |
Ensembl Acc Id: | ENSP00000355618 ⟸ ENST00000366658 |
Ensembl Acc Id: | ENSP00000435420 ⟸ ENST00000459891 |
Ensembl Acc Id: | ENSP00000394547 ⟸ ENST00000435927 |
RefSeq Acc Id: | XP_054194282 ⟸ XM_054338307 |
- Peptide Label: | isoform X1 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q9H2C2-F1-model_v2 | AlphaFold | Q9H2C2 | 1-271 | view protein structure |
RGD ID: | 6787124 | ||||||||
Promoter ID: | HG_KWN:7800 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | ENST00000366658, NM_001122835, NM_024525, OTTHUMT00000092232, OTTHUMT00000092233, OTTHUMT00000092362, OTTHUMT00000092639, OTTHUMT00000092641, OTTHUMT00000092642, OTTHUMT00000092644, UC009XFI.1, UC009XFJ.1, UC009XFK.1, UC009XFL.1 | ||||||||
Position: |
|
RGD ID: | 6859256 | ||||||||
Promoter ID: | EPDNEW_H2790 | ||||||||
Type: | initiation region | ||||||||
Name: | ARV1_1 | ||||||||
Description: | ARV1 homolog, fatty acid homeostasis modulator | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:29561 | AgrOrtholog |
COSMIC | ARV1 | COSMIC |
Ensembl Genes | ENSG00000173409 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Ensembl Transcript | ENST00000310256 | ENTREZGENE |
ENST00000310256.7 | UniProtKB/Swiss-Prot | |
ENST00000366658.6 | UniProtKB/TrEMBL | |
ENST00000435927 | ENTREZGENE | |
ENST00000435927.5 | UniProtKB/TrEMBL | |
ENST00000450711.5 | UniProtKB/TrEMBL | |
ENST00000459891.1 | UniProtKB/TrEMBL | |
GTEx | ENSG00000173409 | GTEx |
HGNC ID | HGNC:29561 | ENTREZGENE |
Human Proteome Map | ARV1 | Human Proteome Map |
InterPro | Arv1 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
KEGG Report | hsa:64801 | UniProtKB/Swiss-Prot |
NCBI Gene | 64801 | ENTREZGENE |
OMIM | 611647 | OMIM |
PANTHER | PROTEIN ARV1 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PTHR14467 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | Arv1 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PharmGKB | PA134935092 | PharmGKB |
PROSITE | PROKAR_LIPOPROTEIN | UniProtKB/TrEMBL |
UniProt | A0A0A0MRI7_HUMAN | UniProtKB/TrEMBL |
A8KAI4 | ENTREZGENE | |
ARV1_HUMAN | UniProtKB/Swiss-Prot | |
H0YEB4_HUMAN | UniProtKB/TrEMBL | |
H7C0E7 | ENTREZGENE, UniProtKB/TrEMBL | |
H7C484 | ENTREZGENE, UniProtKB/TrEMBL | |
Q5VSN7 | ENTREZGENE | |
Q5VSN8 | ENTREZGENE | |
Q5VSN9 | ENTREZGENE | |
Q5VSP0 | ENTREZGENE | |
Q5VSP2 | ENTREZGENE | |
Q9H2C2 | ENTREZGENE | |
Q9H2H2 | ENTREZGENE | |
Q9H5V6 | ENTREZGENE | |
Q9UFF5 | ENTREZGENE | |
UniProt Secondary | A8KAI4 | UniProtKB/Swiss-Prot |
Q5VSN7 | UniProtKB/Swiss-Prot | |
Q5VSN8 | UniProtKB/Swiss-Prot | |
Q5VSN9 | UniProtKB/Swiss-Prot | |
Q5VSP0 | UniProtKB/Swiss-Prot | |
Q5VSP2 | UniProtKB/Swiss-Prot | |
Q9H2H2 | UniProtKB/Swiss-Prot | |
Q9H5V6 | UniProtKB/Swiss-Prot | |
Q9UFF5 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2015-09-29 | ARV1 | ARV1 homolog, fatty acid homeostasis modulator | ARV1 homolog, fatty acid homeostatsis modulator | Symbol and/or name change | 5135510 | APPROVED | |
2015-07-07 | ARV1 | ARV1 homolog, fatty acid homeostatsis modulator | ARV1 fatty acid homeostatsis modulator | Symbol and/or name change | 5135510 | APPROVED | |
2015-06-23 | ARV1 | ARV1 fatty acid homeostatsis modulator | ARV1 homolog (S. cerevisiae) | Symbol and/or name change | 5135510 | APPROVED |